200例中孕引产的临床观察  

Clinical observation of 200 middle period of pregnancy

作　　者：王新华 

机构地区：[1]湖北省孝感市云梦县计划生育服务站,432500

出　　处：《中国医学创新》2009年第28期72-73,共2页Medical Innovation of China

摘　　要：目的探讨中孕引产对象在行羊膜腔注药前服用米非司酮的可行性和必要性。方法收集笔者所在计划生育服务站的临床实例,分为原始组和对照组,对照组在经腹壁行羊膜腔穿刺注入依沙丫啶100 mg前,空腹分服米非司酮150 mg。结果对照组的流产时间明显短于原始组,且无明显的副作用,其他指标无显著差异。结论对于中孕引产对象,在行羊膜腔注入依沙丫啶前分服米非司酮100 mg可明显缩短流产时间,深受引产对象欢迎,其可行性是肯定的,值得广大基层计划生育服务站同仁们参考。Objective Taking the control study of two groups of clinical examples to certify the feasibility and necessity taking mifepristoo before the object of pregnancy having amniotic injection. Methods The cases of two years were divided into two groups： the original group and the control group. The patients in the control group were assigned to take 150 mg mifepriston before puncturing into 100 mg rivanol to amniotic through the abdominal wall. Results The abortion time of the control group turned out to be significantly shorter than the original group, and there were no obvious side effects, other indicators turned out to have no significant difference. Condusion Taking 100 mg mifepristone before the amniotic injection of rivanol can significantly shorten the abortion time. This method wins warm welcome of the object of pregnancy. It＇s feasibility is affirmative. It deserves the reference of wide peer of basic family planning service stations.

关 键 词：中孕引产 米非司酮 流产时间 

分 类 号：R719.3[医药卫生—妇产科学]